KEGG   DRUG: PexelizumabHelp
Entry
D10023                      Drug                                   

Name
Pexelizumab (USAN/INN)
Sequence
MDMRVPAQLL GLLLLWLRGA RCDIQMTQSP SSLSASVGDR VTITCGASEN IYGALNWYQR
KPGKAPKLLI YGATNLADGV PSRFSGSGSG TDFTLTISSL QPEDFATYYC QNVLNTPLTF
GQGTKVEIKR TGGGGSGGGG SGGGGSQVQL VQSGAEVKKP GASVKVSCKA SGYIFSNYWI
QWVRQAPGQG LEWMGEILPG SGSTEYTENF KDRVTMTRDT STSTVYMELS SLRSEDTAVY
YCARYFFGSS PNWYFDVWGQ GTLVTVSS
  Type
Peptide
Efficacy
Anti-complement C5 antibody
Comment
Monoclonal antibody
Complement inhibitor used to reduce the impact of complement-mediated injuries sustained during cordiopulmonary bypass
Target
C5 [HSA:727] [KO:K03994]
Brite
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Immune system
   Complement and coagulation
    C5
     D10023  Pexelizumab (USAN/INN)
BRITE hierarchy
Other DBs
CAS: 219685-93-5
PubChem: 135626744
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system